NCT00115050
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
Not specified
Clinical trial condition
Lentivirus Infections
Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.
5,643 public trials
304 recruiting studies
Lentivirus Infections trial results
NCT01371175
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- KAVI (Kenya AIDS Vaccine Initiative) Nairobi, Kenya
- Guys and St. Thomas' Hospital London, United Kingdom
Completed
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
NCT00904384
- Conditions
- Blood-Borne Infections, COPD, Chronic Disease, +21 more
- Locations
-
- Hospital Universitario Son Dureta Palma de Mallorca, Balearic Islands, Spain
NCT00503347
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
- Locations
-
- Impact Clinical Research Los Angeles, California, United States
- Orange Coast Medical Center Newport Beach, California, United States
- AIDS Research Consortium of Atlanta Atlanta, Georgia, United States
- Johns Hopkins University, Center for Viral Hepatitis Baltimore, Maryland, United States
- Conditions
- Bioavailability, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
- Locations
-
Not specified
NCT00744887
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
- Locations
-
Not specified
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
Not specified
Completed
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients
NCT00481390
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
- Locations
-
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Dublin, Ireland
- GSK Investigational Site Alkmaar, Netherlands
- GSK Investigational Site Amsterdam, Netherlands
Completed
Development of a New HIV Vaccine
NCT00051922
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States